Tryptamine Therapeutics has successfully completed obese-subject dosing in the phase 1b study of its novel IV-infused ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel ...

I tried the Qure Skin-care Micro-Infusion System. Read my honest review and check out photos from the skin-care treatment.

Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among ...

25, 2024 — Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the new results of an ...

Researchers sought to determine whether cilta-cel would have similar results in a real-world RRMM population as in a clinical trial population.

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...

Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held medical device ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...